The combination of LA with other compounds may have more therapeutic potential than monotherapy
Some patients also seek review after serious vision events described in medical records as sudden vision loss, which some individuals refer to as sudden blindness, though these allegations are evaluated carefully based on ophthalmology findings and differential diagnosis
Acknowledgements The authors acknowledge support from the National Institutes of Health (grants R01-CA131524, P01 CA025874 and 5T32CA177555-02), the Gerson and Barbara Bass Bakar Distinguished Professorship in Cancer Research and the Terry Patters Memorial Foundation
We understand the operational challenges raised by commenters regarding system interoperability and the potential impact on smaller practices and believe our flexibility for small practices to report quality measures in the quality ASM performance category at the TIN-level, as further described in section III.C.2.d.(1).(b)., help address this concern
NeuroGuard uses the active form, pyridoxal-5-phosphate (P5P)
They are complementary, not competitive
